These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 38177123)
1. Bivalent activity of super-enhancer RNA LINC02454 controls 3D chromatin structure and regulates glioma sensitivity to temozolomide. Shi T; Guo D; Zheng Y; Wang W; Bi J; He A; Fan S; Su G; Zhao X; Zhao Z; Song Y; Sun S; Li P; Zhao Z; Shi J; Lu W; Zhang L Cell Death Dis; 2024 Jan; 15(1):6. PubMed ID: 38177123 [TBL] [Abstract][Full Text] [Related]
2. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis. Deng Y; Zhu H; Xiao L; Liu C; Meng X Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781 [TBL] [Abstract][Full Text] [Related]
3. The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis. Wei Y; Duan S; Gong F; Li Q Biochem Biophys Res Commun; 2022 May; 603():153-159. PubMed ID: 35294905 [TBL] [Abstract][Full Text] [Related]
4. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma. Han B; Meng X; Wu P; Li Z; Li S; Zhang Y; Zha C; Ye Q; Jiang C; Cai J; Jiang T Theranostics; 2020; 10(7):3351-3365. PubMed ID: 32194873 [No Abstract] [Full Text] [Related]
5. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/ Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728 [No Abstract] [Full Text] [Related]
6. Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p/MGMT axis in glioma. Geng X; Zhang Y; Lin X; Zeng Z; Hu J; Hao L; Xu J; Wang X; Wang H; Li Q Cell Death Dis; 2022 Jul; 13(7):596. PubMed ID: 35817771 [TBL] [Abstract][Full Text] [Related]
7. PSMG3-AS1 enhances glioma resistance to temozolomide via stabilizing c-Myc in the nucleus. Zhou L; Huang X; Zhang Y; Wang J; Li H; Huang H Brain Behav; 2022 May; 12(5):e2531. PubMed ID: 35380741 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294. Hua L; Huang L; Zhang X; Feng H J Biosci; 2020; 45():. PubMed ID: 32975228 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression. Wu Y; Yao Y; Yun Y; Wang M; Zhu R Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31409725 [TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p. Li H; Liu Q; Chen Z; Wu M; Zhang C; Su J; Li Y; Zhang C Cell Death Dis; 2021 Mar; 12(3):252. PubMed ID: 33674567 [TBL] [Abstract][Full Text] [Related]
11. miR-23b-5p promotes the chemosensitivity of temozolomide via negatively regulating TLR4 inĀ glioma. Gao K; Wang T; Qiao Y; Cui B Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):979-987. PubMed ID: 34110366 [TBL] [Abstract][Full Text] [Related]
12. FOXM1-mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K/AKT/mTOR signaling pathway. Guo L; Wu Z Neuropathology; 2022 Oct; 42(5):430-446. PubMed ID: 35701983 [TBL] [Abstract][Full Text] [Related]
13. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma. Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway. Yin H; Cui X Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501 [No Abstract] [Full Text] [Related]
15. UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma. Zhou K; Wang D; Du X; Feng X; Zhu X; Wang C Acta Biochim Biophys Sin (Shanghai); 2024 Jun; 56(6):916-926. PubMed ID: 38634120 [TBL] [Abstract][Full Text] [Related]
16. miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM). He Z; Cheng M; Hu J; Liu L; Liu P; Chen L; Cao D; Tang J J Transl Med; 2022 Oct; 20(1):443. PubMed ID: 36183123 [TBL] [Abstract][Full Text] [Related]
17. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Li C; Feng S; Chen L Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913 [TBL] [Abstract][Full Text] [Related]
18. LncRNA-XIST interacts with Du P; Zhao H; Peng R; Liu Q; Yuan J; Peng G; Liao Y Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28831025 [TBL] [Abstract][Full Text] [Related]
19. Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/ Han C; Wang S; Wang H; Zhang J Cancer Biother Radiopharm; 2021 Sep; 36(7):537-548. PubMed ID: 32644821 [No Abstract] [Full Text] [Related]
20. GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas. He H; Liang L; Jiang S; Liu Y; Huang J; Sun X; Li Y; Jiang Y; Cong L Cell Death Dis; 2024 Mar; 15(3):205. PubMed ID: 38467631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]